Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

Mikihiro Kirara, Phillip Anson Low

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Nerve blood flow (NBF) is reduced in experimental diabetic neuropathy (EDN), but the mechanism of its reduction is uncertain. We tested the hypothesis that reduced NBF might be due to alterations of nitric oxide synthase (NOS) and endothelin of microvascular endothelial cells of sciatic nerve. We evaluated epineurial arteriolar vasoreactivity in response to superfused test agents. NBF was measured using microelectrode H2 polarography. Vasoconstrictor responses to endothelin-1 (ET-1; 10-1, 10-7, 10-8, 10-9, 10-10 M showed dose-response curves with similar EC50 values, indicating no change in potency. We applied the NOS inhibitor NG-nitro-l-arginine and observed reduced inhibition of NBF in EDN, correctable with insulin treatment and also with infused L-arginine. We conclude that vasoreactivity is disturbed in EDN, and is due to a combination of an impairment of NOS activity with reduced NO and increased endothelin effect (normal receptor sensitivity and increased plasma values) in EDN. Hyperglycemia is likely to be the mechanism of NOS inhibition since insulin treatment reversed this abnormality.

Original languageEnglish (US)
Pages (from-to)180-185
Number of pages6
JournalExperimental Neurology
Volume132
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Diabetic Neuropathies
Nitric Oxide Synthase
Nitric Oxide
Endothelins
Arginine
Insulin
Polarography
Microelectrodes
Vasoconstrictor Agents
Endothelin-1
Sciatic Nerve
Hyperglycemia
Endothelial Cells

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. / Kirara, Mikihiro; Low, Phillip Anson.

In: Experimental Neurology, Vol. 132, No. 2, 1995, p. 180-185.

Research output: Contribution to journalArticle

@article{5024e9645fc0445b9d859f44f13f9686,
title = "Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy",
abstract = "Nerve blood flow (NBF) is reduced in experimental diabetic neuropathy (EDN), but the mechanism of its reduction is uncertain. We tested the hypothesis that reduced NBF might be due to alterations of nitric oxide synthase (NOS) and endothelin of microvascular endothelial cells of sciatic nerve. We evaluated epineurial arteriolar vasoreactivity in response to superfused test agents. NBF was measured using microelectrode H2 polarography. Vasoconstrictor responses to endothelin-1 (ET-1; 10-1, 10-7, 10-8, 10-9, 10-10 M showed dose-response curves with similar EC50 values, indicating no change in potency. We applied the NOS inhibitor NG-nitro-l-arginine and observed reduced inhibition of NBF in EDN, correctable with insulin treatment and also with infused L-arginine. We conclude that vasoreactivity is disturbed in EDN, and is due to a combination of an impairment of NOS activity with reduced NO and increased endothelin effect (normal receptor sensitivity and increased plasma values) in EDN. Hyperglycemia is likely to be the mechanism of NOS inhibition since insulin treatment reversed this abnormality.",
author = "Mikihiro Kirara and Low, {Phillip Anson}",
year = "1995",
doi = "10.1016/0014-4886(95)90023-3",
language = "English (US)",
volume = "132",
pages = "180--185",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

AU - Kirara, Mikihiro

AU - Low, Phillip Anson

PY - 1995

Y1 - 1995

N2 - Nerve blood flow (NBF) is reduced in experimental diabetic neuropathy (EDN), but the mechanism of its reduction is uncertain. We tested the hypothesis that reduced NBF might be due to alterations of nitric oxide synthase (NOS) and endothelin of microvascular endothelial cells of sciatic nerve. We evaluated epineurial arteriolar vasoreactivity in response to superfused test agents. NBF was measured using microelectrode H2 polarography. Vasoconstrictor responses to endothelin-1 (ET-1; 10-1, 10-7, 10-8, 10-9, 10-10 M showed dose-response curves with similar EC50 values, indicating no change in potency. We applied the NOS inhibitor NG-nitro-l-arginine and observed reduced inhibition of NBF in EDN, correctable with insulin treatment and also with infused L-arginine. We conclude that vasoreactivity is disturbed in EDN, and is due to a combination of an impairment of NOS activity with reduced NO and increased endothelin effect (normal receptor sensitivity and increased plasma values) in EDN. Hyperglycemia is likely to be the mechanism of NOS inhibition since insulin treatment reversed this abnormality.

AB - Nerve blood flow (NBF) is reduced in experimental diabetic neuropathy (EDN), but the mechanism of its reduction is uncertain. We tested the hypothesis that reduced NBF might be due to alterations of nitric oxide synthase (NOS) and endothelin of microvascular endothelial cells of sciatic nerve. We evaluated epineurial arteriolar vasoreactivity in response to superfused test agents. NBF was measured using microelectrode H2 polarography. Vasoconstrictor responses to endothelin-1 (ET-1; 10-1, 10-7, 10-8, 10-9, 10-10 M showed dose-response curves with similar EC50 values, indicating no change in potency. We applied the NOS inhibitor NG-nitro-l-arginine and observed reduced inhibition of NBF in EDN, correctable with insulin treatment and also with infused L-arginine. We conclude that vasoreactivity is disturbed in EDN, and is due to a combination of an impairment of NOS activity with reduced NO and increased endothelin effect (normal receptor sensitivity and increased plasma values) in EDN. Hyperglycemia is likely to be the mechanism of NOS inhibition since insulin treatment reversed this abnormality.

UR - http://www.scopus.com/inward/record.url?scp=0029011459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029011459&partnerID=8YFLogxK

U2 - 10.1016/0014-4886(95)90023-3

DO - 10.1016/0014-4886(95)90023-3

M3 - Article

C2 - 7540553

AN - SCOPUS:0029011459

VL - 132

SP - 180

EP - 185

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -